Mesoderm is one of the three primary germ layers formed during embryonic development, along with ectoderm and endoderm. It arises during gastrulation, a crucial phase in early embryogenesis, when the blastula transforms into a trilaminar structure. Mesoderm occupies the middle layer, situated between the outer ectoderm and inner endoderm. From the mesoderm, various tissues and organs of the body develop, including the skeletal system, muscular system, cardiovascular system, kidneys, and reproductive organs. The mesoderm gives rise to mesenchymal cells, which have the capacity to differentiate into different cell types, contributing to the diversity of tissues and organs. The intricate process of mesodermal differentiation and migration is tightly regulated by signaling molecules and transcription factors. Aberrations in mesodermal development can lead to congenital anomalies and disorders affecting multiple organ systems. Understanding the molecular and cellular events during mesoderm formation is pivotal for elucidating embryonic development and has implications for regenerative medicine and understanding disease origins. Ongoing research continues to uncover the complexities of mesoderm specification and differentiation, advancing our knowledge of early embryonic patterning and providing insights into potential therapeutic strategies for developmental disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy